Data / Form D filings / PALISADE BIO, INC.
PALISADE BIO, INC.: Form D filings
PALISADE BIO, INC., a biotechnology company in Carlsbad, CA, filed 13 Form D notices with the SEC between 2010 and 2024. The latest, on May 10, 2024, reports $4 million sold of a $4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7750 EL CAMINO REAL, SUITE 2A, Carlsbad, CA, 92009
- Phone
- (858) 704-4900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1357459
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 10, 2024 | New notice | $3,999,942 | $3,999,942 | 1 | May 6, 2024 | sec.gov | |
| Feb 13, 2024 | New notice | $2,502,717 | $2,502,717 | 15 | Feb 1, 2024 | sec.gov | |
| Apr 10, 2023 | New notice | $4,003,205 | $4,003,205 | 9 | Apr 5, 2023 | sec.gov | |
| Jan 19, 2023 | New notice | $2,500,000 | $2,500,000 | 6 | Jan 4, 2023 | sec.gov | |
| May 20, 2022 | New notice | $2,356,127 | $2,356,127 | 5 | May 10, 2022 | sec.gov | |
| Jan 28, 2020 | New notice | $7,555,553 | $7,555,553 | 3 | Jan 22, 2020 | sec.gov | |
| May 31, 2017 | New notice | $42,000 | $42,000 | 2 | May 17, 2017 | sec.gov | |
| Dec 19, 2016 | New notice | $20,000,000 | $20,000,000 | 1 | Dec 12, 2016 | sec.gov | |
| May 23, 2016 | New notice | $1,100,000 | $1,080,000 | $20,000 | 3 | May 12, 2016 | sec.gov |
| Dec 4, 2014 | Amendment | $10,000,000 | $10,000,000 | 1 | Oct 28, 2014 | sec.gov | |
| Oct 31, 2014 | New notice | $10,000,000 | $10,000,000 | 1 | Oct 28, 2014 | sec.gov | |
| Apr 10, 2013 | New notice | $1,778,000 | $1,778,000 | 3 | Mar 22, 2013 | sec.gov | |
| Jan 5, 2010 | New notice | $1,500,000 | $1,500,000 | 1 | Dec 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Binxian Wei | Director | |
| J.D. Finley | Executive Officer, Director | |
| Margery Fischbein | Director | |
| Mitchell Jones | Executive Officer | |
| Donald Williams | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 6, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PALISADE BIO, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.